Beta-D-Glucan in Patients with Haematological Malignancies
(1-3)-beta-D-glucan (BDG) is an almost panfungal marker (absent in zygomycetes and most cryptococci), which can be successfully used in screening and diagnostic testing in patients with haematological malignancies if its advantages and limitations are known. The aim of this review is to report the d...
Κύριοι συγγραφείς: | Malgorzata Mikulska, Elisa Balletto, Elio Castagnola, Alessandra Mularoni |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
MDPI AG
2021-12-01
|
Σειρά: | Journal of Fungi |
Θέματα: | |
Διαθέσιμο Online: | https://www.mdpi.com/2309-608X/7/12/1046 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis
ανά: Siobhan O’Regan, κ.ά.
Έκδοση: (2022-05-01) -
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves
ανά: Letizia Cattaneo, κ.ά.
Έκδοση: (2023-01-01) -
Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019
ανά: Laurène Cachera, κ.ά.
Έκδοση: (2021-05-01) -
Co-recognition of β-glucan and chitin and programming of adaptive immunity to Aspergillus fumigatus.
ανά: Nansalmaa eAmarsaikhan, κ.ά.
Έκδοση: (2015-04-01) -
Serum Beta-D-Glucan in the Diagnosis of Invasive Fungal Disease in Neonates, Children and Adolescents: A Critical Analysis of Current Data
ανά: Laura Ferreras-Antolin, κ.ά.
Έκδοση: (2022-11-01)